Although the response of the T-cell lines to peptide-loaded autologous DCs appeared higher than tumor cell lines, unloaded DCs didn’t stimulate PD-L1241-265-specific CD4+ T-cells as much as tumor cell lines (Fig. 3d). This evidence concerns the gene CD4 and neoplasm.